| 3 / 3 | Ongoing grants |
| 14 / 9 | Completed research grants |
| 3 / 3 | Ongoing scholarships in Brazil |
| 39 / 29 | Completed scholarships in Brazil |
| 1 / 1 | Ongoing scholarships abroad |
| 3 / 3 | Completed scholarships abroad |
| 63 / 48 | All research grants and scholarships |
| Associated processes | |
Advanced search
Adriana Castello Costa Girardi
CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Secretaria da Saúde (São Paulo - Estado). Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP). Instituto do Coração Professor Euryclides de Jesus Zerbini (INCOR) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Adriana C. Girardi received a B.A. in Pharmacology and Biochemistry (1996) and a Ph.D. (2002) in Physiology at University of São Paulo. From 2002 to 2005, she was a postdoctoral fellow in the Aronson lab (Department of Internal Medicine, Section of Nephrology, Yale University). Currently, she is a principal investigator in the Laboratory of Genetics and Molecular Cardiology, Incor, HC-USP and Professor at FMUSP. She has experience in Renal Physiology, Cardiorenal Pharmacology and Biochemistry. Her major scientific interest is understanding blood pressure regulation and cardiovascular disease. Recently, her research group has investigated how therapies for diabetes affect cardiovascular disease progression and hypertension. javascript:void(0) (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Research grants
- Mechanisms underlying the inhibitory effect of gliflozins on NHE3 activity in the renal proximal tubule, AP.R
- Direct effects of SGLT2 inhibitors on cardiac cells exposed to uremic toxins, AP.R SPRINT
- Pleiotropic effects of antidiabetic agents and their pharmacological targets: renoprotective mechanisms beyond glycemic control, AP.TEM
- Modulation of ACE2 in experimental hypertension and in response to treatment with ACE inhibitors and ARBs: potential implications for COVID-19 severity and therapeutic targets, AP.R
- Interplay between dipeptidyl peptidase-4 and Angiotensin II on renal proximal tubule NHE3-mediated sodium reabsorption and blood pressure regulation, AP.R SPRINT
- I International Cardiorenal Meeting, AO.R
(Only some records are available in English at this moment)
Scholarships in Brazil
- Mechanisms underlying the inhibitory effect of gliflozins on NHE3 activity in the renal proximal tubule, BP.JD
- Biochemical characterization of the NHE3-dipeptidyl peptidase 4 interaction in the renal proximal tubule, BP.TT
- Role of endogenous GLP-1 in protecting against salt-sensitive hypertension, BP.DD
- Isolation, identification, and validation of new renal tubular targets of glyflozins, BP.PD
- Bidirectional interaction between SGLT2 and NHE3 in the renal proximal tubule, BP.IC
- Impairment of postprandial GLP-1 bioavailability and renal GLP-1R activation in experimental hypertension: role of salt consumption, BP.IC
(Only some records are available in English at this moment)
Scholarships abroad
Total / Available in English
- Renato de Oliveira Crajoinas
- Flavia Leticia Martins
- Nancy Amaral Reboucas
- Daniel Francisco de Arruda Junior
- Thiago Matheus Santos Rios
- Andréia Boaro
- Gabriela Catão Diniz Braga
- Suely Lopes Gomes
- Felipe Theocharides Oricchio
- Bruna Piccolo Muniz Pacheco
- Fernanda de Alcântara Savignano
- Silmara Larissa Rossetto